Barclays lifts Blue Owl Capital price target to $10 as peers report earnings

Barclays analysts raised their price target for Blue Owl Capital (NYSE:OWL) from $9.00 to $10.00 and kept an equal‑weight rating, suggesting a modest downside potential. Other research houses have recently issued targets ranging from $9.10 (Credit Suisse) to $13.22 (consensus) and mixed ratings.

Pulmonx Corporation announced its second‑quarter 2026 results, reporting worldwide revenue of $22.8 million, a 5 % decline year‑over‑year. U.S. revenue fell 4 % to $14.2 million while international revenue dropped 6 % to $8.6 million, primarily due to the absence of sales in China. The company posted a record gross margin of 78 % and reduced its net loss by 34 % compared with the prior year.

Canada Goose Holdings held its first‑quarter 2027 earnings call, presenting results in Canadian dollars. Chairman and CEO Dani Reiss, CFO Neil Bowden, and other senior executives discussed the quarter’s performance, with analysts from Goldman Sachs, Raymond James, TD Cowen, Wells Fargo, Evercore ISI and Barclays participating in the Q&A session.